Globus Medical (GMED) Revenue (2011 - 2026)

Globus Medical (GMED) has reported Revenue for 16 consecutive years, with $789.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 5.94% year-over-year to $789.6 million; the trailing twelve-month figure through Jun 2026 stood at $3.1 billion (up 19.74% YoY), and the FY2025 full-year result was $2.9 billion, up 16.65% from the prior year.
• Revenue improved to $789.6 million in Q2 2026 per GMED's latest filing, from $759.9 million in the prior quarter.
• Across five years, Revenue topped out at $826.4 million in Q4 2025 and bottomed at $230.5 million in Q1 2022.
• Historically, Revenue has averaged $533.3 million across 5 years, with a median of $611.6 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Revenue jumped 124.6% in 2023, then fell 1.41% in 2025.
• Over 5 years, Revenue stood at $274.5 million in 2022, then jumped by 124.6% to $616.5 million in 2023, then rose by 6.61% to $657.3 million in 2024, then climbed by 25.73% to $826.4 million in 2025, then slipped by 4.45% to $789.6 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $789.6 million, $759.9 million, and $826.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.